Related Experiment Video
Updated: Jan 9, 2026
Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
Published on: February 9, 2022
Fractional exhaled nitric oxide (FeNO) in chronic obstructive respiratory diseases is associated with the
Thuy Chau Nguyen1, Hoa Vi Thi Tran1, Thanh Hiep Nguyen1
1Department of Family Medicine, Pham Ngoc Thach University of Medicine, Polyclinic of Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
Background:
Among chronic obstructive respiratory diseases (CORDs), the fractional exhaled nitric oxide (FeNO) is a marker of eosinophilic airway inflammation. Few data on FeNO in CORD are available in Vietnam. In this study, we aimed to relate the FeNO with the clinical and functional characteristics of CORD in Vietnam.
Methods:
A cross-sectional study was conducted in 235 patients with chronic respiratory symptoms and airways limitation. Clinical evaluation was obtained by questionnaire; pre- and post-bronchodilator (BD) spirometry, eosinophil counts, allergen skin tests and FeNO were measured. Patients were considered as chronic obstructive pulmonary disease (COPD), asthmatics or asthma COPD overlap (ACO) based on GINA/GOLD guidelines. The FeNO levels were related to clinical, spirometric and inflammatory parameters.
Results:
They were 93 COPD, 93 ACO and 49 asthmatics. The concentration of FeNO was high (≥25 ppb) in 69.4% asthmatics, 55.9% of ACO and 34.4% COPD. A high FeNO was more frequent among women, younger, asthmatics, former- or non-smokers, low severity (fewer exacerbations and lower airways limitation), BD responsiveness and type 2 (T2) inflammation [history of allergy, elevated blood eosinophils count (BEC), positive skin tests]. A low FeNO was more frequent in patients with X-ray emphysema or history of tuberculosis. The FeNO level correlated positively with the blood eosinophils and the BD responsiveness in non-smokers but negatively with the basal level of airflow limitation.
Conclusions:
In Vietnamese non-smokers with chronic obstructive respiratory disease, FeNO is a type 2 biomarker and a significant predictor of BD responsiveness. We hypothesized that this might predict the response to inhaled corticosteroids (ICS).
More Related Videos
05:46A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...